Skip to content
Facebook Twitter Linkedin
InMed-logo-01
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amended2024-12-30
S-1General form for registration of securities under the Securities Act of 19332024-12-23
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
S-8Securities to be offered to employees in employee benefit plans2024-12-20
8-KCurrent report2024-12-192024-12-18
8-KCurrent report2024-12-182024-12-13
SCHEDULE 13GForm - SCHEDULE 13G2024-12-18
8-KCurrent report2024-11-202024-11-19
8-KCurrent report2024-11-152024-11-14
10-QQuarterly report [Sections 13 or 15(d)]2024-11-142024-09-30
SC 13G/AStatement of acquisition of beneficial ownership by individuals - amended2024-11-14
8-KCurrent report2024-11-122024-11-08
SC 13GStatement of acquisition of beneficial ownership by individuals2024-11-12
8-KCurrent report2024-11-052024-11-01
DEF 14AOther definitive proxy statements2024-10-282024-12-18
8-KCurrent report2024-10-282024-10-28
DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material2024-10-28
8-KCurrent report2024-10-242024-10-24
8-KCurrent report2024-10-232024-10-22
424B3Prospectus [Rule 424(b)(3)]2024-10-17
8-KCurrent report2024-09-302024-09-30
10-KAnnual report [Section 13 and 15(d), not S-K Item 405]2024-09-302024-06-30
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next »

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More
InMed-logo-mono

#1445 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

  • INM-901 for Alzheimer’s Disease
  • INM-089 for Age-related Macular Degeneration
  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • Novel Analogs

MANUFACTURING

  • BayMedica – Rare Cannabinoid Ingredients
  • Cannabinoid Manufacturing Expertise
  • IntegraSyn™ Cannabinoid Manufacturing

Investor

  • News
  • Events
  • Stock Information
  • Corporate Governance
  • Financials & AGM Materials
  • Filings
  • Presentations
  • Media & Videos
  • Investor Contact

CORPORATE

  • Management
  • Board of Directors
  • Scientific Advisors
  • Partners and Collaborators
  • Careers
  • Contact

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • Cannabinoid Manufacturing Economics 101
  • GMP Manufacturing Standards by Product Type
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2025 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On:
Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*